InvestorInvesting in the future of life sciences and technology.

Brandon Capital is a leading life science venture capital firm based in Australasia, focusing on transforming medical research breakthroughs into therapies. It has a strong global presence with partnerships in the US and UK.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Brandon Capital is a life science venture capital firm based in Australasia, with a global presence supported by partnerships in the United States and the United Kingdom. The firm focuses on transforming medical research breakthroughs into therapies that improve patient outcomes. Founded to support life science companies from early-stage seed investment through to expansion capital, Brandon Capital primarily operates in Australia and New Zealand. The firm invests in various sectors, including oncology, neuroscience, cardiovascular, and digital health, collaborating with medical research institutes to create investment opportunities.
Brandon Capital invests in life science companies, particularly in biotechnology and pharmaceuticals. The firm supports companies at various stages, from proof-of-concept to commercialization, with a focus on oncology, neuroscience, cardiovascular, and digital health sectors. Their investment strategy is bolstered by collaborations with medical research institutes and hospitals to source and create investment opportunities.
Brandon Capital adds value to its portfolio companies through its unique Brandon BioCatalyst initiative, which collaborates with over 50 medical research institutions to support the development and commercialization of early-stage biomedical discoveries. This network provides proprietary deal flow and access to critical resources for portfolio companies.
Brandon Capital focuses on life science companies, particularly in biotechnology and pharmaceuticals, investing at various stages from seed to expansion capital.
Startups can pitch to Brandon Capital through their website at brandoncapital.vc or by emailing info@brandoncapital.com.au.
Brandon Capital's unique Brandon BioCatalyst initiative collaborates with over 50 medical research institutions, providing proprietary deal flow and access to critical resources for portfolio companies.
Brandon Capital invests in companies across North America, Europe, Asia, Oceania, and specifically Australia and New Zealand.
Brandon Capital typically invests between $500,000 and $10 million in their portfolio companies.
Superscout Pro
Is this page right?Reviewed · How the research works